Jenburkt Pharmaceuticals LtdPharmaceuticalsINE354A01013Standalone₹978.00-14.20 (-1.43%)Jun-26
Valuation
Market Cap₹431.62 Cr
TTM PE13.15x
Forward PE14.28x
PEG0.60
Book Value₹389.21
P/B2.51x
TTM EPS₹74.39
Fwd EPS₹68.48
TTM Revenue₹168.72 Cr
TTM PAT₹32.83 Cr
TTM EBITDA₹40.80 Cr
TTM EBIT₹37.78 Cr
Last Qtr PAT₹5.89 Cr
Last Qtr EBITDA₹6.02 Cr
Last Qtr EBIT₹5.38 Cr
Profitability
ROE19.11%
ROCE25.00%
TTM NPM19.46%
TTM EBITDA %24.18%
Curr OPM16.57%
Last OPM24.31%
Curr NPM—
Last NPM—
Curr EPS₹13.34
Last EPS₹24.58
Balance sheet
Equity₹4.41 Cr
Reserve₹167.36 Cr
Total Debt₹1.98 Cr
D/E0.01x
Interest %2.21%
Curr Interest₹0.13 Cr
Price / range
Close₹978.00
vs 52W High-25.97%
vs 52W Low+3.60%
MA50—
MA200—
Returns
1D-1.43%
1W-2.85%
1M-6.83%
3M-17.00%
6M-3.59%
1Y-12.83%
2Y-13.76%
3Y+39.71%
5Y+100.70%
Diwali-11.16%
Sector peers — Pharmaceuticals
Financial Results
Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS
Standalone
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Consolidated
16 lines · 1 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Corporate Actions
Dividends, bonus issues, and stock splits